1-3 of 3
lymphoblastic leukemia
Close
Sort by
Journal Articles

Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency

Clinical Trials & Observations
Sandheeah Ramdeny, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, Ajay Vora
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2153–2155.
https://doi.org/10.1182/bloodadvances.2021004284
Published: 2021
Journal Articles

Replication timing alterations in leukemia affect clinically relevant chromosome domains

Juan Carlos Rivera-Mulia, Takayo Sasaki, Claudia Trevilla-Garcia, Naoto Nakamichi, David J. H. F. Knapp, Colin A. Hammond, Bill H. Chang, Jeffrey W. Tyner, Meenakshi Devidas, Jared Zimmerman, Kyle N. Klein, Vivek Somasundaram, Brian J. Druker, Tanja A. Gruber, Amnon Koren, Connie J. Eaves, David M. Gilbert
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3201–3213.
https://doi.org/10.1182/bloodadvances.2019000641
Published: 2019
Includes: Supplemental data
Journal Articles

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia

Ross Kinstrie, Dimitris Karamitros, Nicolas Goardon, Heather Morrison, Mike Hamblin, Lisa Robinson, Richard E. Clark, Mhairi Copland, Paresh Vyas
Journal: Blood Advances
Blood Adv (2016) 1 (3): 160–169.
https://doi.org/10.1182/bloodadvances.2016000810
Published: 2016
Includes: Supplemental data